This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Orii, A. Articles by Fujii, S. Search for Related Content PubMed PubMed Citation Articles by Orii, A. Articles by Fujii, S. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Substance via MeSH Medline Plus Health Information Uterine Cancer

Altered Post-Translational Modification of Redox Factor 1 Protein in Human Uterine Smooth Muscle Tumors

Department of Gynecology and Obstetrics (A.O., M.K., S.F.), Kyoto University Faculty of Medicine, Kawahara-cho, Shogoin, Kyoto 606-507, Japan; Department of Biological Responses (H.M., J.Y.), Institute for Virus Research, Kyoto University, Kawahara-cho, Shogoin, Kyoto 606-8507, Japan; and Department of Obstetrics and Gynecology (T.N., Y.-L.Z., K.K., I.K.), Shinshu University School of Medicine, Matsumoto 390-8621, Japan

Address all correspondence and requests for reprints to: Shingo Fujii, M.D., Department of Gynecology and Obstetrics, Kyoto University Faculty of Medicine, 54, Kawahara-cho, Shogoin, Kyoto 606-8507, Japan. E-mail: . sfu{at}kuhp.kyoto-u.ac.jp

Abstract

Uterine leiomyomas are the most common benign smooth muscle tumors in the myometrium. The expression of redox factor 1 (Ref-1), a DNA repair enzyme and redox-modifying factor, was studied in the myometrium and uterine smooth muscle tumors to investigate the relevance of Ref-1 in the growth regulation of the tumors. Two forms of Ref-1 protein were detected, using three antibodies against different epitopes of Ref-1. The abundance of the large form of Ref-1 was increased in leiomyoma extracts relative to myometrial tissue extracts, and the large form was dominant in cell lines derived from leiomyosarcomas. A single mRNA transcript was detected in the same samples, leading us to hypothesize that the differentially migrating forms are the result of posttranslational modification(s). In vitro incubation of leiomyoma tissue extract lead to a shift from the large form to the small form, and this conversion was inhibited by either protease or phosphatase inhibitors. Finally, the relative abundance of the large form of Ref-1 was found to correlate with proliferating cell nuclear antigen levels, suggesting a correlation with increased proliferation. These results indicate that altered posttranslational modification of Ref-1 is involved in uterine smooth muscle tumorigenesis.

This article has been cited by other articles:

				X. Luo, L. Ding, J. Xu, R. S. Williams, and N. Chegini Leiomyoma and Myometrial Gene Expression Profiles and Their Responses to Gonadotropin-Releasing Hormone Analog Therapy Endocrinology, March 1, 2005; 146(3): 1074 - 1096. [Abstract] [Full Text] [PDF]